Results 231 to 240 of about 7,735,427 (345)

Now that we all know that primary prevention in mental health is great, whatis it? [PDF]

, 2000
Emory L. Cowen
openalex   +1 more source

Age‐Related Changes in Myeloid Cells and Their Impact on Subcutaneous Melanoma Growth in Mice

Aging and Cancer, EarlyView.
Our findings reveal that age‐related changes in subcutaneous melanoma growth and immunotherapy response are context‐dependent. In models where tumor growth and treatment resistance increase with age, this effect is partly driven by enhanced immunosuppression from myeloperoxidase‐active Gr‐1⁺ myeloid cells.
Kaitlyn M. Landreth, Dylan D. Thomas, Remi Nohoesu, Angisha Basnet, F. Heath Damron, Mary Garland‐Kledzik, Emel Sen Kilic, Tracy W. Liu   +7 more
wiley   +1 more source

Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort. [PDF]

JACC Adv
Zeis TM, Brennan D, Costa-Scharplatz M, Cho L.   +3 more
europepmc   +1 more source

An Evaluation of the cumulative effects of participation in a primary prevention program.

, 1996
Jo-Ann Monker
openalex   +2 more sources

The rise and fall of aspirin in the primary prevention of cardiovascular disease

The Lancet, 2019
Inbar Raber, Cian P. McCarthy, M. Vaduganathan, Deepak L. Bhatt, J. McEvoy   +4 more
semanticscholar   +1 more source

Research progress on the metabolic transformation of Shenling Baizhu San under the influence of the gut microbiota

Advanced Chinese Medicine, EarlyView.
Abstract The gut microbiota plays a pivotal role in maintaining host metabolic homeostasis and overall physiological functions. Shenling Baizhu San (SLBZS), a time‐honored classical prescription for tonifying Qi, strengthening the spleen, removing dampness, and arresting diarrhea, has shown broad clinical efficacy in digestive disorders.
Jinlan Di, Xiaochun Zhang
wiley   +1 more source

It's Prime Time for Primary Prevention. [PDF]

Acta Cardiol Sin
Chao TH, Wu YW.
europepmc   +1 more source

Aspirin for Primary Prevention of Cardiovascular Events.

Journal of the American College of Cardiology, 2019
Hesham K. Abdelaziz, Marwan Saad, N. Pothineni, M. Megaly, R. Potluri, Mohammed Saleh, D. L. C. Kon, D. Roberts, Deepak L. Bhatt, H. Aronow, J. Abbott, J. Mehta   +11 more
semanticscholar   +1 more source

Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age‐ and BMI‐Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Prognostication of disease course and prediction of treatment response in multiple sclerosis is an unmet need. We compared the performance of serum neurofilament light chain Z scores (age‐ and BMI‐adjusted) with absolute concentrations for the prediction of response to disease‐modifying therapy.
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, Johanna Oechtering, Sabine Schaedelin, Lisa Hofer, Amar Zadic, Juan Francisco Vilchez Gomez, Lester Melie‐Garcia, Alessandro Cagol, Riccardo Galbusera, Sebastian Finkener, Patrice Lalive, Marjolaine Uginet, Stefanie Müller, Caroline Pot, Amandine Mathias, Renaud Du Pasquier, Robert Hoepner, Andrew Chan, Giulio Disanto, Chiara Zecca, Marcus D’Souza, Lars G. Hemkens, Tobias Derfuss, Özgür Yaldizli, Patrick Roth, Claudio Gobbi, David Brassat, Björn Tackenberg, Henrik Zetterberg, Tjalf Ziemssen, Heinz Wiendl, Klaus Berger, Marco Hermesdorf, Fredrik Piehl, Ludwig Kappos, Cristina Granziera, Ahmed Abdelhak, David Leppert, Eline A. J. Willemse, Pascal Benkert, Jens Kuhle, Swiss Multiple Sclerosis Cohort Study (SMSC)   +43 more
wiley   +1 more source

Designing an intervention to prevent suicide: PROSPECT (Prevention of Suicide in Primary Care Elderly: Collaborative Trial).

, 1999
Martha L. Bruce, Jane L. Pearson
openalex